EPCAM and neoplasm: To better understand the role of a “stemness” marker of CD133 in the progression and metastasis of primary tumor, further studies are warranted preferably by analyzing a panel of potential “stemness” markers such as CD44, ALDH, EpCAM as well as CD133 in the future [14, 31].